Literature DB >> 27096999

Muscular weakness represents the main limiting factor of walk, functional independence and quality of life of myelopathy patients associated to HTLV-1.

Renata Costa Caiafa1, Marco Orsini2, Lilian R Felicio3, Marzia Puccioni-Sohler1.   

Abstract

UNLABELLED: HTLV-1-associated myelopathy is a progressive disabling disease associated with gait abnormalities.
OBJECTIVE: To identify and quantify the main muscles affected by weakness and spasticity, their impact on gait, functional capacity and on quality of life of HTLV-1-associated myelopathy patients.
METHOD: We evaluated lower limbs muscular strength according to the Medical Research Council scale, spasticity according to the modified Ashworth scale, daily activities according to the Barthel Index and quality of life according to the Short-Form Health Survey-36 of 26 HTLV-1-associated myelopathy patients.
RESULTS: The muscles most affected by weakness included the dorsal flexors and knee flexors. Spasticity predominated in the hip adductor muscles and in plantar flexors. Assistance for locomotion, minimal dependence in daily activities, limitations in functional capacity and physical aspects were the most common findings.
CONCLUSION: The impairment of gait, functional dependence and quality of life were predominantly a consequence of intense muscle weakness in HTLV-1-associated myelopathy patients.

Entities:  

Mesh:

Year:  2016        PMID: 27096999     DOI: 10.1590/0004-282X20160019

Source DB:  PubMed          Journal:  Arq Neuropsiquiatr        ISSN: 0004-282X            Impact factor:   1.420


  7 in total

1.  Health state utility values in people living with HTLV-1 and in patients with HAM/TSP: The impact of a neglected disease on the quality of life.

Authors:  Carolina Rosadas; Tatiane Assone; Marina Yamashita; Adine Adonis; Marzia Puccioni-Sohler; Marisa Santos; Arthur Paiva; Jorge Casseb; Augusto C P Oliveira; Graham P Taylor
Journal:  PLoS Negl Trop Dis       Date:  2020-10-16

2.  Therapeutic effects of virtual reality video gaming on functional mobility, balance, and gait speed in individuals with tropical spastic paraparesis: A randomized crossover clinical trial.

Authors:  Erika Pedreira da Fonseca; Katia Nunes Sá; Rebeca Freitas Reis Nunes; Camille Rosa de Jesus Souza; Mayra Castro de Matos Sousa; Elen Beatriz Pinto
Journal:  Rev Soc Bras Med Trop       Date:  2021-01-29       Impact factor: 1.581

3.  Balance assessment in HTLV-1 associated myelopathy or tropical spastic paraparesis.

Authors:  Naiane Araújo Patrício; Mônica Andrade Rios; Patrícia Carvalho Barbosa; Jéssica Ramos Ribeiro; Diogo Guedes Vidal; Kátia Nunes Sá; Abrahão Fontes Baptista
Journal:  Rev Soc Bras Med Trop       Date:  2020-11-25       Impact factor: 1.581

4.  Health-Related Quality of Life Evaluation Using the Short Form-36 in Patients With Human T-Lymphotropic Virus Type 1-Associated Myelopathy.

Authors:  Miyuna Kimura; Junji Yamauchi; Tomoo Sato; Naoko Yagishita; Natsumi Araya; Satoko Aratani; Kenichiro Tanabe; Erika Horibe; Toshiki Watanabe; Ariella Coler-Reilly; Misako Nagasaka; Yukari Akasu; Kei Kaburagi; Takayuki Kikuchi; Soichiro Shibata; Hirofumi Matsumoto; Akihito Koseki; Soichiro Inoue; Ayako Takata; Yoshihisa Yamano
Journal:  Front Med (Lausanne)       Date:  2022-04-11

5.  Work ability and associated factors in people living with human T-cell leukemia virus type 1.

Authors:  Dayana Alves Costa; Fernando Martins Carvalho; Nicolle Melo Vieira; Gleicy Gabriela Spínola Carneiro Falcão; Viviane Almeida Sarmento; Carlos Brites; Liliane Lins-Kusterer
Journal:  Rev Soc Bras Med Trop       Date:  2022-08-05       Impact factor: 2.141

6.  Impact of fractures and orthopedic surgeries in patients with HTLV-1 associated myelopathy/tropical spastic paraparesis.

Authors:  Pablo Julca-Copello; Alvaro Schwalb; Rodrigo Cachay; Martín Tipismana; Carolina Alvarez; Fernando Mejía; Elsa González-Lagos; Eduardo Gotuzzo
Journal:  Rev Soc Bras Med Trop       Date:  2020-09-11       Impact factor: 1.581

7.  Limitations in daily activities, risk awareness, social participation, and pain in patients with HTLV-1 using the SALSA and Participation scales.

Authors:  Cintia Yolette Urbano Pauxis Aben-Athar; Denise da Silva Pinto; Sandra Souza Lima; Izaura Maria Vieira Cayres Vallinoto; Ricardo Ishak; Antonio Carlos Rosário Vallinoto
Journal:  Braz J Infect Dis       Date:  2020-09-14       Impact factor: 3.257

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.